A 2018 review in the International Journal of Yoga by Paula R Pullen from Morehouse School of Medicine and team concludes that gentle yoga can safely improve exercise capacity, inflammatory markers, autonomic balance, and quality of life in medically stable heart failure patients when added to standard care. The authors urge larger trials and explore tele-yoga, exergames, and smart home technologies to expand access to yoga-based heart failure rehabilitation.
A 2018 review in the International Journal of Yoga by Paula R Pullen from Morehouse School of Medicine and team highlights yoga as a promising adjunct therapy for people living with heart failure, complementing standard cardiology care rather than replacing it. The authors summarize randomized trials showing that carefully adapted Hatha or Iyengar-style yoga can improve exercise capacity, quality of life, flexibility, and key biomarkers of inflammation and oxidative stress in medically stable heart failure patients. Reported benefits include reductions in interleukin 6, C reactive protein, N terminal pro B type natriuretic peptide, blood pressure, and even fewer implantable defibrillator firings in some studies.
Because heart failure patients often struggle with fatigue, breathlessness, and muscle wasting, the review pays close attention to safety and intensity. Available metabolic data from healthy adults show that most traditional Hatha sequences fall in the light to moderate range of energy demand, roughly comparable to slow-to-brisk walking, and the authors recommend gentler styles, chair-based adaptations, and avoidance of heated rooms or vigorous flow classes for this population. Beyond simple conditioning, they outline several mechanisms: yoga postures and breathing appear to stimulate the vagus nerve, enhance parasympathetic activity, improve heart rate variability and baroreflex sensitivity, and may trigger anti-inflammatory, pro-resolving mediators via stretch of connective tissue and muscle.
The review also emphasizes mindfulness and meditation components, which may further downregulate the hypothalamic–pituitary–adrenal axis, reduce perceived stress, improve sleep, and ease depression and anxiety common and prognostically important in heart failure. Looking ahead, the authors call for multicenter, long-term trials to refine “dose” and style of yoga, and they see major potential in tele-yoga, exergames, and low-cost sensor or smartphone platforms to deliver supervised home-based yoga, especially for patients who cannot attend cardiac rehab due to cost, transport, or caregiving responsibilities.
